Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in NAFLD
NCT00529204Phase 2Terminated
- Sponsor
- University of California, Davis
- Start
- Oct 2007
- Primary completion
- Jul 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in non-alcoholic fatty liver disease (NAFLD), sponsored by University of California, Davis. Started Oct 2007; status: terminated.
02
Drugs
exenatide
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT00529204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529204.